ARCHIVES

Isis 3521 Gets Fast-track Status For FDA Review.

This article is from The Cancer Letter archive.

Vol. 26 No. 44 | December 1, 2000

Download PDF Visit The Full Archive

Related Articles

ACS Expresses Concern About “Fletcher Report” On Mammography

May 7, 1993

DCE Board Approves Recompetition Of Two Major Contracts

October 30, 1987

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

February 24, 2006

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990

BRMP Investigators Find New Lung Tumor Antigen, Seek Developers

January 8, 1982

In Brief: Obey Fears Hangup On Abortion Funding will Kill Labor-Hew Appropriations Bill

July 6, 1979